Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 01)
Enalapril Maleate Tablet
Product Images NDC 50090-7222
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Enalapril Maleate (NDC 50090-7222). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 02)
This appears to be a comparison of the incidence of various side effects between Enatapril maleate and Placebo in a study. Common side effects include dizziness, diarrhea, headache, chest pain, hypotension, and urinary tract infections among others. The data provides insight into the frequency of these effects associated with the two treatments.*
Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 03)
This text provides dosing guidelines for Creatinine based on renal function status and dialysis treatment. Specific dosages are recommended for patients with normal renal function, mild impairment, and moderate to severe impairment, as well as for dialysis patients. It also includes a mention of adjusting dosage on non-dialysis days based on blood pressure response and warns of Anaphylactoid Reactions during Membrane Exposure.*
Label Image (Lbl500907222)
This is a description of a medication package containing 30 tablets of a product with the name "ERALAPRIL MALEATE" with a strength of 5 mg per tablet. The product code is 5133-0.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
